Abstract:The apicomplexan parasite Cryptosporidium is a leading cause of childhood diarrhea in developing countries. Current treatment options are inadequate and multiple preclinical compounds are being actively pursued as potential drugs for cryptosporidiosis. Unlike most apicomplexans, Cryptosporidium spp. sequentially replicate asexually and then sexually within a single host to complete their lifecycles. Anti-cryptosporidial compounds are generally identified or tested through in vitro phenotypic assays that only assess the asexual stages. Therefore, compounds that specifically target the sexual stages remain unexplored. In this study, we leveraged the ReFRAME drug repurposing library against a newly devised multi-readout imaging assay to identify small-molecule compounds that modulate macrogamont differentiation and maturation. RNA-seq studies confirmed selective modulation of macrogamont differentiation for 10 identified compounds (9 inhibitors and 1 accelerator). The collective transcriptomic profiles of these compounds indicates that translational repression accompanies Cryptosporidium sexual differentiation, which we validated experimentally. Additionally, cross comparison of the RNA-seq data with promoter sequence analysis for stage-specific genes converged on a key role for an Apetala 2 (AP2) transcription factor (cgd2_3490) in differentiation into macrogamonts. Finally, drug annotation for the ReFRAME hits indicates that an elevated supply of energy equivalence in the host cell is critical for macrogamont formation. Cryptosporidium species are intracellular intestinal parasites that cause prolonged diarrhea in immunocompromised people and children. Recent in vitro studies of the Cryptosporidium life cycle indicate the parasite undergoes three rounds of asexual replication followed by an obligatory sexual cycle. This life cycle suggests the novel possibilities of therapy or prevention by targeting sexual differentiation and reproduction. To identify drug-like inhibitors and tool compounds, we developed a screening assay for female gametocytogenesis and screened the ReFRAME library. Our screen identified selective sexual differentiation inhibitors. We then studied the impacts of inhibitor treatment on RNA expression. Comparison of our results to publicly available female-specific gene expression data confirmed that the inhibitors selectively modulated differentiation. We then found that ribosomal protein expression falls during Cryptosporidium female gametocytogenesis, and we experimentally demonstrated corresponding translational repression. Further analysis of promoter regions of coordinately regulated genes implicated a conserved promoter motif and an Apetala 2 transcription factor in female gametocytogenesis. This study identifies a set of tool compounds that selectively modulate Cryptosporidium female gametocytogenesis, provides new insights into female differentiation, and lays the groundwork for future investigations to determine if obligatory sexual reproduction is a vulnerability that can be exploited for therapy or prevention of cryptosporidiosis.

A comparison of the physical properties of four new generation flexible ureteroscopes: (de)flection, flow properties, torsion stiffness, and optical characteristics.

Mendelian segregation and high recombination rates facilitate genetic analyses in

Sympatric Recombination in Zoonotic Cryptosporidium Leads to Emergence of Populations with Modified Host Preference

Specific skin ulcers in Hodgkin's disease.

Global population genomics of two subspecies of Cryptosporidium hominis during 500 years of evolution

A Cytological Revisit on Parthenogenetic Artemia and the Deficiency of a Meiosis-Specific Recombinase DMC1 in the Possible Transition from Bisexuality to Parthenogenesis.

Transcriptional control of the Cryptosporidium life cycle

From germline genome to highly fragmented somatic genome: genome-wide DNA rearrangement during the sexual process in ciliated protists

Dynamic genome plasticity during unisexual reproduction in the human fungal pathogen Cryptococcus deneoformans

Cryptosporidium felis differs from other Cryptosporidium spp. in codon usage

Multiple independent losses of crossover interference during yeast evolutionary history

High-Resolution Sex-Specific Linkage Maps of the Mouse Reveal Polarized Distribution of Crossovers in Male Germline

Stepwise recombination suppression around the mating-type locus in an ascomycete fungus with self-fertile spores

Co-inheritance of recombined chromatids maintains heterozygosity in a parthenogenetic ant

Cryptosporidium life cycle small molecule probing implicates translational repression and an Apetala 2 transcription factor in macrogamont differentiation

Genetic and Genomic Analyses Reveal Boundaries between Species Closely Related to Cryptococcus Pathogens

Comparative Analysis of Apicomplexa and Genomic Diversity in Eukaryotes

Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: A retrospective multicentre study.

Recurrent loss of crossover interference punctuates the recombination landscape across yeast species

A Genome Resequencing-Based Genetic Map Reveals the Recombination Landscape of an Outbred Parasitic Nematode in the Presence of Polyploidy and Polyandry

Genome Duplication Increases Meiotic Recombination Frequency: A Saccharomyces cerevisiae Model